ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BHVN Biohaven Ltd

34.09
0.48 (1.43%)
Last Updated: 10:59:35
Delayed by 15 minutes

Period:

Draw Mode:

Volume 126,602
Bid Price
Ask Price
News -
Day High 34.99

Low
16.45

52 Week Range

High
62.21

Day Low 33.10
Share Name Share Symbol Market Stock Type
Biohaven Ltd BHVN NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.48 1.43% 34.09 10:59:35
Open Price Low Price High Price Close Price Previous Close
33.28 33.10 34.99 33.61
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
3,109 126,602 US$ 34.22 US$ 4,331,949 - 16.45 - 62.21
Last Trade Type Quantity Price Currency
11:00:06 1 US$ 34.1308 USD

Biohaven (BHVN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-35k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Biohaven Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.8B 81.58M - 0 -408.17M -5.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Biohaven News

Date Time Source News Article
5/29/202406:30PR Newswire (US)Biohaven Showcases Broad Innovative Portfolio and Pipeline..
5/29/202406:15PR Newswire (US)Biohaven Doses First Patient with its Novel Trop-2 Directed..
5/17/202415:42Edgar (US Regulatory)Form 8-K - Current report
5/17/202415:41Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]
5/09/202415:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
5/09/202415:14Edgar (US Regulatory)Form 8-K - Current report
5/09/202415:05PR Newswire (US)Biohaven Reports First Quarter 2024 Financial Results and..
4/22/202415:05PR Newswire (US)Biohaven Announces Closing of Public Offering and Full..
4/17/202415:05PR Newswire (US)Biohaven Announces Proposed Public Offering of Common Shares
4/13/202408:00PR Newswire (US)Biohaven Showcases Innovative Neuroscience Portfolio with 20..
2/29/202415:16Edgar (US Regulatory)Form 8-K - Current report
2/29/202415:05PR Newswire (US)Biohaven Reports Fourth Quarter and Full Year 2023 Financial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BHVN Message Board. Create One! See More Posts on BHVN Message Board See More Message Board Posts

Historical BHVN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week36.2637.1532.6834.49948,785-2.17-5.98%
1 Month40.1241.2026.8035.401,629,852-6.03-15.03%
3 Months55.3260.461226.8043.091,458,043-21.23-38.38%
6 Months33.2862.2126.8044.681,304,1700.812.43%
1 Year22.7062.2116.4535.321,201,38611.3950.18%
3 Years90.75152.567.1063.121,074,298-56.66-62.44%
5 Years56.05152.567.1061.44942,357-21.96-39.18%

Biohaven Description

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders.